We are live on ! Find out more
MREO

Mereo BioPharma
MREO

18 hedge funds and large institutions have $4.39M invested in Mereo BioPharma in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.88% more ownership

Funds ownership: 0% → 1.88% (+1.9%)

Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
+$3.04M
2
BI
BVF Inc
California
+$2.29M
3
Renaissance Technologies
Renaissance Technologies
New York
+$857K
4
PA
Perceptive Advisors
New York
+$785K
5
CL
CSS LLC
Illinois
+$337K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Primecap Management
1
Primecap Management
California
$1.67M +$3.04M +696,110 New
BI
2
BVF Inc
California
$1.26M +$2.29M +523,382 New
Renaissance Technologies
3
Renaissance Technologies
New York
$494K +$857K +195,923 New
PA
4
Perceptive Advisors
New York
$452K +$785K +179,419 New
CL
5
CSS LLC
Illinois
$195K +$337K +77,152 New
BC
6
Birchview Capital
Vermont
$120K +$208K +47,570 New
State Street
7
State Street
Massachusetts
$40K +$72.2K +16,516 New
BCM
8
Bridgeway Capital Management
Texas
$40K +$73.1K +16,714 New
Morgan Stanley
9
Morgan Stanley
New York
$34K +$58.4K +13,342 New
Bank of America
10
Bank of America
North Carolina
$31K +$52.9K +12,104 New
CC
11
Cannell & Co
New York
$26K +$48.2K +11,025 New
PAM
12
Panagora Asset Management
Massachusetts
$20K +$35.9K +8,210 New
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$3K +$5.69K +1,302 New
TRCT
14
Tower Research Capital (TRC)
New York
$2K +$3.47K +793 New
Wells Fargo
15
Wells Fargo
California
$1K +$1K +229 New
UBS Group
16
UBS Group
Switzerland
$1K +$2.96K +676 New
Barclays
17
Barclays
United Kingdom
– +$35 +8 New
PMFA
18
Plante Moran Financial Advisors
Michigan
– +$210 +48 New

MREO Hedge Fund Activity: Q2 2019 in Review

18 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Mereo BioPharma (MREO) for Q2 2019, worth a combined $4.39M.

Buyers outnumbered sellers: 18 funds opened new MREO positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Primecap Management, opening a new position worth an estimated $3.04M.

  • 18 institutional investors held Mereo BioPharma (MREO) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $4.39M of Mereo BioPharma stock for Q2 2019.
  • 18 funds opened new Mereo BioPharma positions in Q2 2019 and 0 closed out, a net change of +18 holders.
  • The largest Mereo BioPharma buyer in Q2 2019 was Primecap Management, an estimated $3.04M added.

Based on aggregated 13F filings for Q2 2019.